Wytse Hogewerf

Search results

• 2022

  Alpha-Synuclein Lowering and Rescue of Motor Phenotype by miRNA-Based AAV Gene Therapy in In Vivo Parkinson's Disease Models

  Broekmans, S. A., Tornero, C. V., Toonen, L., Valls, M., Erbrink, R., Ronde, K. E., Hogewerf, W., Tolsma, L. E. D., Seinstra, R. I., Janssen, L. L. S., Nollen, E. A. A. & Valles, A., Apr-2022, In: Molecular Therapy. 30, 4, p. 10-10 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2021

  Dose dependent lowering of alpha-synuclein and rescue of motor phenotype by miRNA-based AAV gene therapy

  Broekmans, S. A., Tornero, C. V., Akyol, F., Toonen, L., Kieper, S., Ronde, K. E., Hogewerf, W., Tolsma, E. D., Seinstra, R. I., Janssen, L. L. S., Nolen, E. A. A. & Valles, A., Oct-2021, In: Human Gene Therapy. 32, 19-20, p. A51-A51 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic